ANDREW CARTER: Open Payments
NPI 1568602779 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 8 payments from 5 companies in 2025. Trend: 2023 $49 · 2024 $0 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Corium, LLC | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: CAPLYTA, Azstarys, Qelbree, AUSTEDO XR, REXULTI.
Industry payments across OK — which companies pay providers there.
